New clinical study links Euromed’s Pomanox® to improved key biomarker of ageing Mollet del Vallès (Spain), October 2025 – A double-blind, randomised, placebo-controlled clinical trial published in Nutrients reveals that daily supplementation with Pomanox® leads to a statistically significant increase in insulin-like growth factor-1 (IGF-1) in older adults.[1] IGF-1 supports normal cell growth and repair, and typically declines with age. Pomanox® is a patented, high-polyphenol pomegranate … [Read more...] about Pomegranate polyphenols may support longevity